Press Releases

    Print Page  Close Window
BioMed Realty Trust Announces Promotion of Matthew G. McDevitt to Executive Vice President

SAN DIEGO, March 6 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the promotion of Matthew G. McDevitt to the newly created position of regional executive vice president, overseeing the company's east coast acquisitions, development and leasing activities. Mr. McDevitt previously has served as vice president, acquisitions of BioMed Realty Trust since its inception in August 2004.

"I'm delighted to announce Matt's well-deserved appointment to regional executive vice president," said Alan Gold, president and chief executive officer of BioMed Realty Trust. "His contributions to our company and demonstrated leadership skills have been exceptional, and are evident from our successful expansion into the east coast markets, particularly the acquisition and integration of the $525 million Cambridge portfolio in Boston. Matt has the respect and confidence of our entire management team, and will remain very valuable to the continued growth of BioMed Realty Trust."

Prior to joining BioMed, Mr. McDevitt served as President of McDevitt Real Estate Services, Inc. (MRES), which Mr. McDevitt formed in October 1997 as a full service real estate provider focusing on the life science industry. Before founding MRES, Mr. McDevitt spent ten years as a commercial real estate broker in the Washington, D.C. metropolitan area. Mr. McDevitt received his Bachelor of Arts Degree in Business from Gettysburg College.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on acquiring, developing, owning, leasing and managing laboratory and office space for the life science industry. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry, and its properties and primary acquisition targets are generally located in markets with well established reputations as centers for scientific research, including Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey. Additional information is available at

SOURCE BioMed Realty Trust, Inc.
CONTACT: John F. Wilson, II, Chief Financial Officer of BioMed Realty Trust, Inc., +1-858-485-9840
Web site:
03/06/2006 05:00 EST